126 related articles for article (PubMed ID: 15359930)
1. FDG-PET imaging in duodenal cancer.
Watanabe N; Hayashi S; Kato H; Shimizu M; Kamisaki Y; Noguchi K; Kishida M; Matsunari I; Hisada K; Seto H
Ann Nucl Med; 2004 Jun; 18(4):351-3. PubMed ID: 15359930
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET in a case of multiple bone metastases of gastric cancer.
Nakai T; Okuyama C; Kubota T; Ushijima Y; Nishimura T
Ann Nucl Med; 2005 Feb; 19(1):51-4. PubMed ID: 15770974
[TBL] [Abstract][Full Text] [Related]
3. Metastatic brain lesions may demonstrate photopenia on FDG-PET.
Liu Y
Clin Nucl Med; 2008 Apr; 33(4):255-7. PubMed ID: 18356662
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of F-18 FDG-PET in detection of multiple endocrine tumors with duodenal carcinoid.
Hayasaka K; Nihashi T; Matsuura T; Itoh K; Tokuda H
Comput Med Imaging Graph; 2007 Apr; 31(3):191-4. PubMed ID: 17383156
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms.
Sperti C; Pasquali C; Fiore V; Bissoli S; Chierichetti F; Liessi G; Pedrazzoli S
Am J Surg; 2006 Jun; 191(6):743-8. PubMed ID: 16720142
[TBL] [Abstract][Full Text] [Related]
7. Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management.
van Kouwen MC; Drenth JP; van Krieken JH; van Goor H; Friederich P; Oyen WJ; Nagengast FM
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):270-4. PubMed ID: 16292630
[TBL] [Abstract][Full Text] [Related]
8. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of whole-body FDG-PET/CT for detecting brain metastases from non-central nervous system tumors.
Kitajima K; Nakamoto Y; Okizuka H; Onishi Y; Senda M; Suganuma N; Sugimura K
Ann Nucl Med; 2008 Aug; 22(7):595-602. PubMed ID: 18756362
[TBL] [Abstract][Full Text] [Related]
10. [(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
Hu M; Li MH; Kong L; Liu NB; Yang GR; Yu JM
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):699-701. PubMed ID: 19173915
[TBL] [Abstract][Full Text] [Related]
11. 11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
Nomori H; Shibata H; Uno K; Iyama K; Honda Y; Nakashima R; Sakaguchi K; Goya T; Takanami I; Koizumi K; Suzuki T; Kaji M; Horio H
J Thorac Oncol; 2008 Dec; 3(12):1427-32. PubMed ID: 19057268
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.
Jeong HJ; Chung JK; Kim YK; Kim CY; Kim DG; Jeong JM; Lee DS; Jung HW; Lee MC
J Nucl Med; 2002 Nov; 43(11):1432-7. PubMed ID: 12411544
[TBL] [Abstract][Full Text] [Related]
13. Intracranial Leptomeningeal Carcinomatosis from Breast Cancer Detected on 18F-FDG PET.
Carra BJ; Clemenshaw MN
J Nucl Med Technol; 2015 Sep; 43(3):227-8. PubMed ID: 25655343
[TBL] [Abstract][Full Text] [Related]
14. Limitation of F-18 fluorodeoxyglucose positron emission tomography in the detection of metastatic adenocarcinoma of brain combining intratumoral hemorrhage.
Miyamoto J; Owada K; Sasajima H; Mineura K
Clin Nucl Med; 2010 Jul; 35(7):554-6. PubMed ID: 20548160
[No Abstract] [Full Text] [Related]
15. [Utility of PET-18FDG in primary tumor site in a patient with cerebral metastases].
Suárez Fernández JP; Serna Macías JA; Domínguez Grande ML; Liaño H; Pozo MA; Maldonado Suárez A
Rev Esp Med Nucl; 2005; 24(4):253. PubMed ID: 16122410
[No Abstract] [Full Text] [Related]
16. Duodenum Cryptococcosis Mimicking Primary Duodenum Cancer on PET/CT Imaging.
Xiu Y; Zhang J; Shi H
Clin Nucl Med; 2018 May; 43(5):335-336. PubMed ID: 29538024
[TBL] [Abstract][Full Text] [Related]
17. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
18. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
Pieterman RM; Que TH; Elsinga PH; Pruim J; van Putten JW; Willemsen AT; Vaalburg W; Groen HJ
J Nucl Med; 2002 Feb; 43(2):167-72. PubMed ID: 11850480
[TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT imaging in prostate adenocarcinoma presenting as isolated brain metastases of unknown origin.
Erhamamcı S; Reyhan M; Alkan O
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):146-7. PubMed ID: 25052407
[No Abstract] [Full Text] [Related]
20. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
